Two new carbapenem antibiotics, northienamycin and 8-epi-thienamycin have been isolated from culture broth of Streptomyces cattleya grown under conditions for thienamycin production. The isolation, structure elucidation and in vitro antibacterial spectra of the new carbapenems are reported. In addition, comparison of the in vitro potency of the corresponding formamidine derivatives to that of MK787 is presented.
Antibacterial Assays Antibacterial activity of partially purified samples was determined by agar disc diffusion assay against Staphylococcus aureus ATCC 6538P using thienamycin or MK787 as standard. Disc diffusion assay results reported in Table 3 employed the KIRSY-BAUER method24> modified only by the use of an agar thickness of 0.2 cm. For the determination of MICs, broth dilution studies were conducted by the microtiter technique. Volumes of 1.5 yl of culture containing 105 colony-forming units (CFU) were transferred by use of a Dynatech MIC-2000 inoculator to microtiter wells containing 0.1 ml of a twofold serial dilution of the antibiotics in Mueller-Hinton broth. The lowest concentration showing an absence of visible turbidity or sediment after 20 hours of incubation at 35°C was designated the MIC. Organisms listed in Tables 3 and 4 include both isolates of typical antibiotic sensitivity and isolates selected for their resistance to i3-lactam antibiotics currently in use.
UV Assay
Total carbapenem concentration in solution was determined by a difference spectrophotometric assay based on the reaction of the carbapenem chromophore (Ama, 297-300 nm) with hydroxylamine at pH 7 to form products exhibiting marginal absorbance at Ama,22>. Since compounds 1 -6 all possess the same carbapenem chromophore and have similar Ama, values, it was assumed that all compounds have the same molar extinction coefficient (s) at Crystalline MK787 monohydrate, 298 nm (s 9,670, 99% NH2OH extinction), was selected as standard. Based on this standard, pure carbapenems have the following E; m, Amax values: 1 (355), 2 (374), 3 (355), 4 (323), 5 (338), 6 (323). The thienamycin sample assayed 85 % pure.
HPLC Assay HPLC assays were carried out using a Waters Assoc. Model 6000A pump and a Waters Assoc. Model U6K injector. Column effluent was monitored at 297300 nm with an LDC SpectroMonitor II Model 1202 UV detector equipped with a flow cell of 10 mm pathlength and a Honeywell Model Electronik 195 recorder. A Spectra Physics Autolab System I Computing Integrator quantitated detector output. All carbapenem pairs were satisfactorily resolved at 30°C using a Waters 10 ttm C16 /t-Bondapak column (4 mm ID x 300 mm) in 0.01 M potassium phosphate pH 7.0. At a flow rate of 1.2 ml/ minute, the retention times (seconds) of the antibiotics are as follows: 2 (283), 5 (350), 1 (435), 3 (465), 4 (562), 6 (615) . Column performance deteriorated significantly with age. The retention times of all components decreased markedly although the relative order of elution did not change. Analysis of 1/3 mixtures was also performed using an Aminex A-5 column (4.6 mm ID x240 mm). The column was operated at ambient temperature in 0.01 M sodium phosphate pH 7.0 containing 25 /.M EDTA. The flow rate was 0.2 ml/minute. Retention times of 1 and 3 were 2,180 seconds and 2,510 seconds respectively.
Analytical Instrumentation NMR spectra were recorded on a Varian SC-300 spectrometer at 6°C in 0.02 M sodium phosphate pD 7.8. Low resolution MS data were collected at 70 eV on an LKB Model 9000 spectrometer. High resolution MS data were measured at 100 eV using a Varian MAT 731 spectrometer. IR , UV, and CD spectra were determined on the following respective instruments: Nicolet Model 7199 FTIR spectrometer, Beckman Model 5260 spectrophotometer, and Jasco Model J-41A spectropolarimeter.
Results
Northienamycin and 8-epi-thienamycin were isolated from S. cattleya fermented to produce thienamycin. Fermentation was carried out in complex medium as described previously.Y2> The isolation process is summarized in Fig. 1 . The first three steps are common with thienamycin isolation and have been reported in detail elsewhere.26> Broth was first adsorbed on Dowex 1X2 (bicarbonate), 50-100 mesh. Crude thienamycin complex was eluted from the resin with carbonic acid and chromatographed in water on Dowex 1X2 (CI-), 50-100 mesh. To this point compounds 2 and 3 co-chromato- thienamycin. In addition, an early thienamycin off-fraction was found by agar disc diffusion assay to have more antibacterial activity than could be accounted for by the HPLC assay of thienamycin content.
The new antibiotic component has been isolated and shown to be northienamycin. In a similar way, a late thienamycin off-fraction from the Amberlite XAD-2 step was analyzed by HPLC using an Aminex A-5 column. An effluent fraction was collected that exhibited less antibacterial activity than expected from the UV assay of the fraction for thienamycin. This result led ultimately to the isolation of 8-epithienamycin whose antibacterial potency is considerably less than that of thienamycin. Because of the pronounced instability of 2 and 3 in solution, successive isolation steps were executed with minimum delay.
The formamidine derivatives of northienamycin and 8-epi-thienamycin were most conveniently prepared by N-formimidoylation of thienamycin and isolation of 5 and 6 as minor constituents of the reaction product.
Isolation of Northienamycin
A sample of early thienamycin off-fractions from the Amberlite XAD-2 chromatography ( Fig. 1) contained 48 mg of northienamycin and 520 mg of thienamycin. The sample, adjusted to pH 7, was chromatographed in two equal portions on 230 ml of Amberlite XAD-2, -400 mesh in water to remove thienamycin. The northienamycin rich cut was lyophilized to 340 mg of 10 % pure antibiotic. The solid was reconstituted in 30 ml of acetone -0.02 mt aqueous KCI (pH 7) 1: 1, and chromatographed at 5°C in the same solvent on 400 ml of Sephadex G-75. Northienamycin concentration in column effluent peaked at 2.6 column volumes. About half of the eluted northienamycin was excluded from the rich cut because of impurities indicated by HPLC assay at 300 nm and 220 nm. The rich cut, containing 11 mg of 2, was further purified by chromatography at 5°C on 200 ml of Dowex 50WX2 (K+), 200400 mesh in 0.01 mt KCI. Appropriate fractions were pooled and adsorbed directly onto 40 ml of Dowex 1X2 (bicarbonate), 200 ~ 400 mesh at 5°C. After washing the column with water, the antibiotic was SEPT. 1983 eluted with cold carbonic acid. Lyophilization of active fractions afforded 3.8 mg of 2 as a white solid, judged to be 60 % pure by UV assay.
Isolation of 8-epi-Thienamycin
A 180 mg sample of lyophilized late thienamycin off-fractions from the Amberlite XAD-2 chromatography ( Fig. 1 ) contained 2.3 mg of 8-epi-thienamycin and 48 mg of thienamycin. The sample was chromatographed in twelve 15-mg portions on 8 ml of Aminex A-5 (Na+). The eluting solvent was 0.01 M sodium phosphate pH 6.9 containing 25 itM EDTA and the flow rate was 0.4 ml/minute. The elution peak of 1 occurs at 1.8 column volumes and that of 3 at 2.1 column volumes. The combined rich cut from the twelve runs was rechromatographed in four portions on the same column and under the same conditions. A final third Aminex A-5 chromatography gave 0.82 mg of 3 containing less than I thienamycin. The product was concentrated to 1 ml and desalted by chromatography in water on 20 ml of Amberlite XAD-2, -400 mesh. Lyophilization gave 1.43 mg of 3 as a white solid, judged to be 44% pure by UV assay.
Isolation of N-Formimidoylnorthienamycin (5) and N-Formimidoyl-8-epi-thienamycin (6) Thienamycin isolated by the process in Fig. 1 typically contains 2 -5 % each of northienamycin (2) and 8-epi-thienamycin (3). Conversion of 32 g of thienamycin to MK787 followed by Dowex 50WX2 chromatography") provided an MK787 tail fraction enriched in the corresponding formamidine derivatives of 2 and 3. The fraction assayed 57 mg of 5, 66 mg of 6, and 500 mg of MK787. When chromatographed in water on 250 ml of Amberlite XAD-2, -400 mesh, the northienamycin derivative eluted at 1. 
Structure of Northienamycin and 8-epi-Thienamycin
It was suspected early in the isolation that 2 and 3 were closely related to thienamycin. The UV spectra of all three compounds exhibit single absorbance maxima at 297 nm, which are destroyed upon treatment with hydroxylamine at pH 7. Both 2 and 3 are unstable in solution and are not retained at pH 7 on Dowex 1X2 (CI-) resin, properties shared by thienamycin.22> The antibacterial profiles are also similar to thienamycin, particularly with respect to anti-Pseudomonas activity (vida infra).
Purified 2 shows strong IR absorption at 1762 cm-1 and 1610 cm-1, consistent with a 3-lactam carbonyl and a carboxylate anion ( Table 1 ). The molecular formula of 2 was established as C10H14N2- The 'H NMR spectrum of 2 (Fig. 2, Table 2 ) shows resonances corresponding to those of CH (5), CH(6), CH2(4), and -SCH2CH,N-of thienamycin. However, the spectrum of 2 lacks the CH, (9) H40,QN2O,SSi3 (FIRMS M+ 488.2019, calcd 488.2017). Therefore, the molecular formula of 3 is C,1H16-N,O,S (MW 272), identical to that of thienamycin. From the close similarity of the 1H NMR spectra of 3 and thienamycin, 3 must be a diastereomer of thienamycin (Fig. 3 , Table 2 ). The CH (6) 
Antibacterial Properties
Antibacterial activity of northienamycin (2) and 8-epi-thienamycin (3) is presented in Table 3 .
Data for thienamycin, cephalothin and carbenicillin are included for comparison. Both 2 and 3 exhibit good broad spectrum activity that includes Pseudomonas aeruginosa. Discounting differences in antibiotic potency, the three carbapenems have similar spectral profiles. Relative potencies of the antibiotics, determined from the geometric means of potencies of data in Table 3 MIC results for formamidine derivatives 4-6 are presented in Table 4 . N-Formimidoylnorthienamycin is more susceptible to P-99 j3-lactamase of Enterobacter cloacae 2646 than either MK787 or Nformimidoyl-8-epi-thienamycin.
Discussion
Two new carbapenem antibiotics, northienamycin and 8-epi-thienamycin, have been isolated from S. cattleya fermentation.
Broth titers are approximately 5 % of that of co-produced thienamycin. Both compounds have trans P-lactam stereochemistry (5R, 6S) and the simple unsubstituted cysteamine side chain of thienamycin and NS-5.12) Northienamycin is the first example of a carbapenem antibiotic with a one carbon side chain at C-6.
Although northienamycin and 8-epi-thienamycin are less potent antibacterial agents than thienamycin, both exhibit good activity against a range of organisms. Their greater effectiveness against P. aeruginosa strains compared to most other carbapenems can be attributed to the amino group in the cysteaminyl side chain. For instance epithienamycin C (MM 22381), the N-acetyl analogue of 8-epithienamycin, is reported ineffective against Pseudomonas.2" Furthermore, epithienamycin C appears to have approximately one-third the overall antibacterial potency of 8-epi-thienamycin. Analogous results have been reported for thienamycin/N-acetylthienamycin and for epithienamycin A/deacetylepithienamycin A. 23 The formamidine derivatives of northienamycin and 8-epi-thienamycin are less active in vitro than MK787.
